Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

The neurodegenerative disease impacts almost 10 million people globally, who at best can hope for therapies that slow and ...

Sildenafil citrate has been found to be safe and effective in the treatment of erectile dysfunction in PD. Clinical diagnosis of Parkinson's disease ... dementia are the best known factors.

"The best medication for Parkinson's will come from Israel. It will be a hybrid medication, and the world's best hybrid ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

"We know that Parkinson's disease patients are at risk," Pronovost says, "so CMOs need to make sure they have a way to ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...